Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Reassessing the risk of natalizumab-associated PML.
Optimal combination of FLAIR and T2-weighted MRI for improved lesion contrast in multiple sclerosis.
FOCIS: Advanced Course in Basic & Clinical Immunology
New data reinforce efficacy of TECFIDERA® (dimethyl fumarate) in MS patients with high disease activity
Clinically isolated syndromes: a new oligoclonal band test accurately predicts conversion to MS.
The role of global and regional gray matter volume decrease in multiple sclerosis.
Rare MEFV variants are not associated with risk to develop multiple sclerosis and severity of disease.
A monoclonal natural human IgM protects axons in the absence of remyelination.
BRIEF: Teva files for Copaxone-Laquinimod patent
12-oxo-phytodienoic acid, a plant-derived oxylipin, attenuates lipopolysaccharide-induced inflammation in microglia.
National MS Society: Patient Management, Care and Rehabilitation Research Grants
An Exploratory Investigation of Social Stigma and Concealment in Patients with Multiple Sclerosis.
Akt Regulates Axon Wrapping and Myelin Sheath Thickness in the PNS.
Rapid, sustained and reversible pharmacodynamics of DAC HYP in MS patients supports mechanism of action via modulation of the IL-2 pathway
American Academy of Neurology Annual Meeting
Neuromyelitis optica spectrum disorders: Comparison according to the phenotype and serostatus.
Eosinophilic Fasciitis-like Disorder Developing in the Setting of Multiple Sclerosis Therapy.
ForuMS: A Virtual Journal Club for MS Clinicians
Moving Targets for Hematopoietic Stem Cell Transplantation for Multiple Sclerosis.
Genzyme’s once-daily, oral AUBAGIO® (teriflunomide) approved in Argentina for the treatment of relapsing multiple sclerosis
Episode 21 with Dr. Paul Matthews discussing imaging in MS
Interferon β-secreting mesenchymal stem cells combined with minocycline attenuate experimental autoimmune encephalomyelitis.
Episode 25 with actor and science advocate Alan Alda discussing communicating science
Biogen slips as FDA extends review of MS drug
Management of multiple sclerosis and the integration of related specialty pharmacy programs within health systems.

Pages